RTTNews | Nov 8, 2021 06:44AM EST

06:44 Monday, November 8, 2021 (RTTNews) - Matinas BioPharma Q3 Loss Attributable To Shareholders $6.8 Mln Or $0.03/Shr Vs Loss $5.7 Mln Or $0.03/Shr Last Eyar

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved